FREEDOM - First Real-Life Evaluation of Enablex Done in ZA Overactive Bladder Patients During a 3 Months Period

Urge Incontinence Bladder Overactivity Study

NCT00475696 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects

NCT02821312 ·Status: UNKNOWN ·Phase: PHASE1

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB)

NCT04545580 ·Status: COMPLETED ·Phase: PHASE2

Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury

NCT03482037 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.

NCT00171145 ·Status: COMPLETED ·Phase: PHASE3

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

NCT00190814 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of DR-3001 Versus Placebo in Women With Overactive Bladder

NCT00196404 ·Status: COMPLETED ·Phase: PHASE2

Darifenacin x Parasacral Transcutaneous Electric Nerve Stimulation for OAB in Patients Infected With Human T-Lymphotropic Virus 1

NCT06616675 ·Status: COMPLETED ·Phase: PHASE4

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

Flexibly adding-on Second Antimuscarinic Agent to the First Antimuscarinics for Refractory Overactive Bladder Syndrome

NCT01824420 ·Status: COMPLETED ·Phase: PHASE4

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

NCT00190996 ·Status: COMPLETED ·Phase: PHASE3

Unilateral Versus Bilateral Neuromodulation Tests in the Treatment of Refractory Idiopathic Overactive Bladder

NCT01558856 ·Status: COMPLETED ·Phase: NA

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

NCT00190567 ·Status: COMPLETED ·Phase: PHASE2

Study The Effects Of Different Doses Of UK-369,003 In Men With Overactive Bladder

NCT00479505 ·Status: COMPLETED ·Phase: PHASE2

Efficacy, Tolerability and Impact on Quality of Life of Propiverine in Patients With Overactive Bladder Syndrome

NCT02024945 ·Status: COMPLETED

Efficacy and Safety of Duloxetine

NCT00190619 ·Status: COMPLETED ·Phase: PHASE3

Local Anesthetic Treatments for Overactive Bladder

NCT00427648 ·Status: TERMINATED ·Phase: PHASE3

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

NCT00190645 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

NCT01598103 ·Status: TERMINATED ·Phase: PHASE2

Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity

NCT00800462 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

NCT00966004 ·Status: COMPLETED ·Phase: PHASE3

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

NCT00244296 ·Status: COMPLETED ·Phase: PHASE4

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

NCT00191204 ·Status: COMPLETED ·Phase: PHASE3

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder

NCT01604928 ·Status: COMPLETED ·Phase: PHASE2

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

NCT04211831 ·Status: COMPLETED ·Phase: PHASE2